BEAM Competitors & Alternatives
Compare Beam Therapeutics Inc with similar stocks in the same industry
Biotechnology
BEAM
Main Stock$36.22
Tradestie Score
69
Market Cap
$2.44B
Revenue Growth
3.2%
Analyst Upside
+41.0%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$36.39
|
$3.92B | - | 61 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$99.08
|
$3.91B | - | 65 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$18.68
|
$3.83B | - | 53 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$17.23
|
$3.68B | - | 57 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$106.38
|
$3.67B | - | 56 | Compare |
|
ADMA
ADMA Biologics, Inc.
|
$8.51
|
$3.59B | 12.2 | 57 | Compare |
|
ACAD
Acadia Pharmaceuticals Inc.
|
$22.53
|
$3.58B | 9.8 | 65 | Compare |
|
LGND
Ligand Pharmaceuticals Inc.
|
$266.27
|
$3.49B | 35.7 | 57 | Compare |
|
TLX
Telix Pharmaceuticals Limited American Depositary Shares
|
$10.19
|
$3.40B | - | 57 | Compare |
|
QURE
uniQure N.V.
|
$48.02
|
$3.39B | - | 59 | Compare |
More BEAM Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
222 stocks in this industry